Literature DB >> 12442808

Visualization of in vivo olfactory uptake and transfer using fluorescein dextran.

B Jansson1, E Björk.   

Abstract

Nasal administration of a 3 kDa fluorescein dextran (FD3) solution to rats resulted in transcellular absorption across the olfactory epithelium and transfer to the olfactory bulb within 15 min. After entering the lamina propria, FD3 was transferred in the connective tissue surrounding the olfactory nerve bundles to the olfactory bulb of the brain. More FD3 was absorbed across the olfactory epithelium than across the respiratory epithelium and to the nasal associated lymphoid tissue. Further, the amount of FD3 crossing the olfactory epithelium was region-dependent, with higher amounts absorbed in the turbinates than in the nasal septum. Plastic embedding and sectioning followed by fluorescence microscopy, enabled simultaneous visualization of FD3 in the mucosa and olfactory bulb, as well as the opportunity to store the tissue blocks for a prolonged period of time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12442808     DOI: 10.1080/1061186021000001823

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  20 in total

1.  Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.

Authors:  Qingfeng Liu; Yehong Shen; Jie Chen; Xiaoling Gao; Chengcheng Feng; Lu Wang; Qizhi Zhang; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

Review 2.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

3.  Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.

Authors:  Irina A Ionescu; Julien Dine; Yi-Chun Yen; Dominik R Buell; Leonie Herrmann; Florian Holsboer; Matthias Eder; Rainer Landgraf; Ulrike Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

4.  Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution.

Authors:  John Douglas Hoekman; Rodney J Y Ho
Journal:  AAPS PharmSciTech       Date:  2011-04-26       Impact factor: 3.246

5.  Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.

Authors:  Jeffrey J Lochhead; Daniel J Wolak; Michelle E Pizzo; Robert G Thorne
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

6.  Intranasal delivery of a peptide with antidepressant-like effect.

Authors:  Virginia Brown; Fang Liu
Journal:  Neuropsychopharmacology       Date:  2014-03-17       Impact factor: 7.853

Review 7.  A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.

Authors:  Asa Peterson; Amy Bansal; Florence Hofman; Thomas C Chen; Gabriel Zada
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

8.  Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

Authors:  John D Hoekman; Pramod Srivastava; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2014-06-06       Impact factor: 3.534

9.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

10.  A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.

Authors:  Jasper Stevens; Ernst Suidgeest; Piet Hein van der Graaf; Meindert Danhof; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2009-05-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.